DrugPatentWatch Database Preview

Adapt Company Profile

« Back to Dashboard

What is the competitive landscape for ADAPT, and what generic alternatives to ADAPT drugs are available?

ADAPT has six approved drugs.

There are eight US patents protecting ADAPT drugs.

There are twenty-four patent family members on ADAPT drugs in fourteen countries and thirty-one supplementary protection certificates in fourteen countries.

Summary for Adapt

International Patents:	24
US Patents:	8
Tradenames:	4
Ingredients:	4
NDAs:	6
Patent Litigation for Adapt:	See patent lawsuits for Adapt

Drugs and US Patents for Adapt

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Adapt	NARCAN	naloxone hydrochloride	SPRAY, METERED;NASAL	208411-001	Nov 18, 2015		RX	Yes	Yes	9,629,965		Y
Adapt	NARCAN	naloxone hydrochloride	SPRAY, METERED;NASAL	208411-001	Nov 18, 2015		RX	Yes	Yes	9,468,747		Y
Adapt	NARCAN	naloxone hydrochloride	INJECTABLE;INJECTION	016636-003	Jun 14, 1982		DISCN	Yes	No

Paragraph IV (Patent) Challenges for ADAPT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Nasal Spray	4 mg/spray		2016-07-15

International Patents for Adapt Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	3349756
Mexico	365383
Japan	2017508800

Supplementary Protection Certificates for Adapt Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2316456	CA 2017 00062	Denmark		PRODUCT NAME: NALTREXON ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER NALTREXONHYDROCHLORID, OG BUPROPION ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER BUPROPIONHYDROCHLORID; REG. NO/DATE: EU/1/14/988 20150330
2316456	C201730057	Spain		PRODUCT NAME: NALTREXONA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, EN PARTICULAR CLORHIDRATO DE NALTREXONA, Y BUPROPION O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN PARTICULAR CLORHIDRATO DE BUPROPION.; NATIONAL AUTHORISATION NUMBER: EU/1/14/988; DATE OF AUTHORISATION: 20150326; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/988; DATE OF FIRST AUTHORISATION IN EEA: 20150326
2316456	LUC00054	Luxembourg		PRODUCT NAME: NALTREXONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR NALTREXONE HYDROCHLORIDE, AND BUPROPION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BUPROPION HYDROCHLORIDE; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Adapt
• Adaptis